MRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells

Biomaterials

Volumn 32, Issue 34, 2011, Pages 9128-9135

  De Temmerman, Marie Luce ^a   Dewitte, Heleen ^a   Vandenbroucke, Roosmarijn E ^a,b   Lucas, Bart ^a   Libert, Claude ^a,b   Demeester, Jo ^a   De Smedt, Stefaan C ^a   Lentacker, Ine ^a   Rejman, Joanna ^a  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Controlled drug release; Gene therapy; Microsphere; MRNA

Indexed keywords

CANCER IMMUNOTHERAPY; CONTROLLED DRUG RELEASE; DENDRITIC CELLS; EXPRESSION LEVELS; IMMUNE SYSTEMS; LIPOPLEXES; LOCALISATION; MESSENGER RNA; MICROBUBBLE CONTRAST AGENTS; MICROBUBBLES; MRNA; PROTEIN EXPRESSIONS; TRANSIENT TRANSFECTION; TUMOR CELLS; UP-REGULATION;

ANTIGENS; CELLS; ENCODING (SYMBOLS); ENZYME ACTIVITY; FLOW CYTOMETRY; GENE THERAPY; LIPOSOMES; MICROSPHERES; RNA; TUMORS; ULTRASONICS;

MOLECULAR BIOLOGY;

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; CD40 ANTIGEN; CD86 ANTIGEN; FIREFLY LUCIFERASE; LIPOPLEX; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL MATURATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; LIPOSOMAL GENE DELIVERY SYSTEM; MICROBUBBLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSIENT TRANSFECTION; ULTRASOUND; UPREGULATION;

ANTIGENS, CD40; ANTIGENS, CD86; CELLS, CULTURED; CONTRAST MEDIA; DENDRITIC CELLS; HUMANS; LIPIDS; MICROBUBBLES; RNA, MESSENGER; TRANSFECTION; UP-REGULATION;

EID: 80053120336     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.024     Document Type: Article

References (43)

1. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
2. Sousa C.R.E. Activation of dendritic cells: translating innate into adaptive immunity. Curr Opin Immunol 2004, 16:21-25.
3. Gilboa E. The makings of a tumor rejection antigen. Immunity 1999, 11:263-270.
4. Dallal R.M., Lotze M.T. The dendritic cell and human cancer vaccines. Curr Opin Immunol 2000, 12:583-588.
5. Banchereau J., Schuler-Thurner B., Palucka A.K., Schuler G. Dendritic cells as vectors for therapy. Cell 2001, 106:271-274.
6. Steinman R.M., Dhodapkar M. Active immunization against cancer with dendritic cells: the near future. Int J Cancer 2001, 94:459-473.
7. Ridgway D. The first 1000 dendritic cell vaccinees. Cancer Invest 2003, 21:873-886.
8. Boczkowski D., Nair S.K., Snyder D., Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996, 184:465-472.
9. Kirk C.J., Mule J.J. Gene-modified dendritic cells for use in tumor vaccines. Hum Gene Ther 2000, 11:797-806.
10. Ponsaerts P., Van Tendeloo V.F.I., Berneman Z.N. Cancer immunotherapy using RNA-loaded dendritic cells. Clin Exp Immunol 2003, 134:378-384. Review.
11. Tavernier G., Andries O., Demeester J., Sanders N.N., De Smedt S.C., Rejman J. mRNA as gene therapeutic: how to control protein expression. J Contr Release 2011, 150:238-247.
12. Breckpot K., Corthals J., Heirman C., Bonehill A., Michiels A., Tuyaerts S., et al. Activation of monocytes via the CD14 receptor leads to the enhanced lentiviral transduction of immature dendritic cells. Hum Gene Ther 2004, 15:562-573.
13. Aicher A., Westermann J., Cayeux S., Willimsky G., Daemen K., Blankenstein T., et al. Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. Exp Hematol 1997, 25:39-44.
14. Hartman Z.C., Appledorn D.M., Amalfitano A. Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res 2008, 132:1-14.
15. Thomas C.E., Ehrhardt A., Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003, 4:346-358.
16. Van Tendeloo V.F.I., Ponsaerts P., Lardon F., Nijs G., Lenjou M., Van Broeckhoven C., et al. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 2001, 98:49-56.
17. Grunebach F., Muller M.R., Nencioni A., Brossart P. Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes. Gene Ther 2003, 10:367-374.
18. Van Meirvenne S., Straetman L., Heirman C., Dullaers M., De Greef C., Van Tendeloo V., et al. Efficient genetic modification of murine dendritic cells by electroporation with mRNA. Cancer Gene Ther 2002, 9:787-797.
19. Tinkov S., Bekeredjian R., Winter G., Coester C. Microbubbles as ultrasound triggered drug carriers. J Pharm Sci 2009, 98:1935-1961.
20. Lentacker I., De Smedt S.C., Sanders N.N. Drug loaded microbubble design for ultrasound triggered delivery. Soft Matter 2009, 5:2161-2170.
21. Pitt W.G., Husseini G.A., Staples B.J. Ultrasonic drug delivery - a general review. Expert Opin Drug Deliv 2004, 1:37-56.
22. Schlicher R.K., Radhakrishna H., Tolentino T.P., Apkarian R.P., Zarnitsyn V., Prausnitz M.R. Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol 2006, 32:915-924.
23. Eliyahu H., Servel N., Domb A.J., Barenholz Y. Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery. Gene Ther 2002, 9:850-858.
24. Schutt E.G., Klein D.H., Mattrey R.M., Riess J.G. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. Angew Chem Int Ed 2003, 42:3218-3235. Review.
25. Song L.Y., Ahkong Q.F., Rong Q., Wang Z., Ansell S., Hope M.J., et al. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim Biophys Acta-Biomembr 2002, 1558:1-13.
26. Shi F.X., Wasungu L., Nomden A., Stuart M.C.A., Polushkin E., Engberts J., et al. Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions. Biochem J 2002, 366:333-341.
27. Lentacker I., Wang N., Vandenbroucke R.E., Demeester J., De Smedt S.C., Sander N.N. Ultrasound exposure of lipoplex loaded microbubbles facilitates direct cytoplasmic entry of the lipoplexes. Mol Pharm 2009, 6:457-467.
28. Rejman J., Tavernier G., Bavarsad N., Demeester J., De Smedt S.C. mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers. J Contr Release 2010, 147:385-391.
29. Suzuki R., Oda Y., Utoguchi N., Namai E., Taira Y., Okada N., et al. A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy. J Contr Release 2009, 133:198-205.
30. Lentacker I., Geers B., Demeester J., De Smedt S.C., Sanders N.N. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol Ther 2010, 18:101-108.
31. Sousa C.R. Essay - dendritic cells in a mature age. Nat Rev Immunol 2006, 6:476-483.
32. Villadangos J.A., Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 2007, 7:543-555.
33. Bonehill A., Van Nuffel A.M.T., Corthals J., Tuyaerts S., Heirman C., Francois V., et al. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients. Clin Cancer Res 2009, 15:3366-3375.
34. Morse M.A., Coleman R.E., Akabani G., Niehaus N., Coleman D., Lyerly H.K. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res 1999, 59:56-58.
35. Lambert L.A., Gibson G.R., Maloney M., Durell B., Noelle R.J., Barth R.J. Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity. Cancer Res 2001, 61:641-646.
36. Bedrosian I., Mick R., Xu S.W., Nisenbaum H., Faries M., Zhang P., et al. Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients. J Clin Oncol 2003, 21:3826-3835.
37. Nestle F.O., Farkas A., Conrad C. Dendritic-cell-based therapeutic vaccination against cancer. Curr Opin Immunol 2005, 17:163-169.
38. Maloy K.J., Erdmann I., Basch V., Sierro S., Kramps T.A., Zinkernagel R.M., et al. Intralymphatic immunization enhances DNA vaccination. Proc Natl Acad Sci U S A 2001, 98:3299-3303.
39. Tagawa S.T., Lee P., Snively J., Boswell W., Ounpraseuth S., Lee S., et al. Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with stage IV melanoma. Cancer 2003, 98:144-154.
40. Taniyama Y., Tachibana K., Hiraoka K., Aoki M., Yamamoto S., Matsumoto K., et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 2002, 9:372-380.
41. Vannan M., McCreery T., Li P., Han Z.G., Unger E., Kuersten B., et al. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. J Am Soc Echocardiogr 2002, 15:214-218.
42. Goldberg B.B., Merton D.A., Liu J.B., Thakur M., Murphy G.F., Needleman L., et al. Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology 2004, 230:727-734.
43. Sever A.R., Mills P., Jones S.E., Cox K., Weeks J., Fish D., et al. Preoperative sentinel node identification with ultrasound using microbubbles in patients with breast cancer. Am J Roentgenol 2011, 196:251-256.